Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-08-31
著者
-
ITOH Kyogo
Departments of Immunology, Kurume University School of Medicine
-
YAMAOKA Takashi
Sumitomo Pharmaceuticals Research Center
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka
-
Itoh Kyogo
久留米大学 医学部免疫学
-
Imaizumi Toshihiro
Cancer Vaccine Development Division Of Kurume University Research Center For Innovative Cancer Thera
-
INOUE Yoshiko
Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Thera
-
GOTOH Masashi
Sumitomo Pharmaceutical Co., Ltd.
-
SHICHIJO Shigeki
Department of Immunology, Kurume University School of Medicine
-
HOSHINO Tomoaki
Department of Immunology, Kurume University School of Medicine
-
IMAI Yasuhisa
Department of Immunology, Kurume University School of Medicine
-
TAKASU Hideo
Sumitomo Pharmaceutical Co., Ltd.
-
IMAI YASUO
Department of Gastroenterology, Faculty of Medicine, The University of Tokyo
-
Itoh K
Department Of Immunology Kurume University School Of Medicine
-
Itoh K
National Cancer Center Hospital East Chiba
-
Itoh K
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Itoh K
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen
-
Itoh Kyogo
Department Of Immunology
-
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
-
TAKASU Hideo
Department of Immunology, Kurume University School of Medicine
-
Shichijo S
Department Of Immunology Kurume University School Of Medicine
-
Shichijo Shigeki
Departments Of Immunology
-
Takasu H
Department Of Immunology Kurume University School Of Medicine
-
Takasu Hideo
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
-
Yamaoka T
Sumitomo Pharmaceuticals Co. Ltd. Osaka
-
Imai Yasuhisa
Departments Of Immunology Kurume University School Of Medicine
-
Imai Yasuhisa
Department Of Immunology Kurume University School Of Medicine
-
Imai Yasuo
Department Of Gastroenterology Faculty Of Medicine The University Of Tokyo
-
Inoue Yoshiko
Cancer Vaccine Development Division Of Kurume University Research Center For Innovative Cancer Thera
-
Gotoh Masashi
Sumitomo Pharmaceutical Co. Ltd.
-
Hoshino Tomoaki
Department Of Immunology Kurume University School Of Medicine
-
Yamaoka Takashi
Sumitomo Pharmaceutical Co. Ltd.
-
Shichijo Shigeki
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
関連論文
- Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- Antitumor Effects of a Novel Lipophilic Platinum Complex (SM-11355) against a Slowly-Groing Rat Hepatic Tumor after Intra-Hepatic Arterial Administration
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- In Vitro Release of SM-11355,cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)]Platinum(II) Suspended in Lipiodol
- In Vitro Cytotoxicity of cis[((1R, 2R)-1,2-Cyclohexanediamine-N, N')bis(myristato)] platinum(II) Suspended in Lipiodol in Rat Hepatoma AH-109A Cells and Human Tumor Cell Lines
- Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
- Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
- Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
- Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver
- Hepatocellular carcinoma depicted as hypoattenuation on CT hepatic arteriography (CTA) and hyperattenuation on CT during arterial portography (CTAP)
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- Case of Werner's syndrome with pancreatic carcinoma
- Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
- Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase
- Personalized peptide vaccines : A new therapeutic modality for cancer
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- Expression of the SART-1 Antigens in Uterine Cancers
- Target molecules in specific immunotherapy against prostate cancer
- Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
- Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
- Expression of MAGE-1 Gene by Esophageal Carcinomas
- Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
- Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
- Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
- Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
- Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
- Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
- Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
- Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
- Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
- Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
- Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
- Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
- A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
- Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
- Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
- Human Tumor Rejection Antigens MAGE1^1
- Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
- Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
- Immunohistochemical and Molecular Analysis of Giant Cell Carcinoma of the Pancreas : A Report of Three Cases
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Mutational Inactivation of Mitotic Checkpoint Genes, hsMAD2 and hBUB1, Is Rare in Sporadic Digestive Tract Cancers
- p16^ Gene Mutations Are Relatively Frequent in Ampullary Carcinomas
- Frequent Somatic Mutations of the APC and p53 Genes in Sporadic Ampullary Carcinomas
- Mutational Analysis of the p53 and K-ras Genes and Allelotype Study of the Rb-1 Gene for Investigating the Pathogenesis of Combined Hepatocellular-Cholangiocellular Carcinomas
- Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
- Primary cancer of the small intestine and mutational analysis of the K-ras and p53 genes
- Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
- Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
- Inhibition of the Release of Bradykinin-Like Substances into the Perfusate of Rat Hind Paw by Neurotropin
- Exploring immune therapy for renal cancer
- A Case of Late-Onset Systemic Lupus Erythematosus with Severe Anemia
- Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes
- Influence of Heat Stimulation on the Amount of Calcitonin Gene-Related Peptide and Neurokinin A in the Subcutaneous Space of the Rat Hind Instep.
- Increase in the Capability of Interleukin 2 Gene-Transduced Renal Cell Carcinoma Cells to Induce Cytotoxic Lymphocytes.
- Comparison between Natural and Immunized Anti-GM1 Antibodies Analyzed by Marker Releasing Rate Assay with Liposome.
- Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer